BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17083036)

  • 1. HIV immunosuppression and antimalarial efficacy: sulfadoxine-pyrimethamine for the treatment of uncomplicated malaria in HIV-infected adults in Siaya, Kenya.
    Shah SN; Smith EE; Obonyo CO; Kain KC; Bloland PB; Slutsker L; Hamel MJ
    J Infect Dis; 2006 Dec; 194(11):1519-28. PubMed ID: 17083036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria.
    Van Geertruyden JP; Mulenga M; Mwananyanda L; Chalwe V; Moerman F; Chilengi R; Kasongo W; Van Overmeir C; Dujardin JC; Colebunders R; Kestens L; D'Alessandro U
    J Infect Dis; 2006 Oct; 194(7):917-25. PubMed ID: 16960779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi.
    Patnaik P; Jere CS; Miller WC; Hoffman IF; Wirima J; Pendame R; Meshnick SR; Taylor TE; Molyneux ME; Kublin JG
    J Infect Dis; 2005 Sep; 192(6):984-91. PubMed ID: 16107950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated falciparum malaria among children with sickle cell trait in Western Kenya.
    Terlouw DJ; Aidoo MA; Udhayakumar V; Kolczak MS; Oloo AJ; Kager PA; Lal AA; Nahlen BL; Kuile FO
    J Infect Dis; 2002 Dec; 186(11):1661-8. PubMed ID: 12447744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members.
    Malamba SS; Mermin J; Reingold A; Lule JR; Downing R; Ransom R; Kigozi A; Hunt BM; Hubbard A; Rosenthal PJ; Dorsey G
    Am J Trop Med Hyg; 2006 Sep; 75(3):375-80. PubMed ID: 16968909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4 T cell activation as a predictor for treatment failure in Ugandans with Plasmodium falciparum malaria.
    Eggena MP; Hopkins H; Barugahare B; Okello M; Ssali F; Mugyenyi P; Rosenthal PJ; Cao H; Dorsey G
    Am J Trop Med Hyg; 2006 Jan; 74(1):41-3. PubMed ID: 16407344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
    Barnes KI; Little F; Mabuza A; Mngomezulu N; Govere J; Durrheim D; Roper C; Watkins B; White NJ
    J Infect Dis; 2008 Jun; 197(11):1605-13. PubMed ID: 18471066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloroquine versus sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum malaria in Savannakhet Province, Lao People's Democratic Republic: an assessment of national antimalarial drug recommendations.
    Mayxay M; Newton PN; Khanthavong M; Tiengkham P; Phetsouvanh R; Phompida S; Brockman A; White NJ
    Clin Infect Dis; 2003 Oct; 37(8):1021-8. PubMed ID: 14523765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of chloroquine and sulfadoxine/pyrimethamine mono- and combined therapy against falciparum malaria in Sudan.
    Elamin SB; Malik el-FM; Ahmed el-DS; Elabadil EK; Mohamad TA
    East Mediterr Health J; 2007; 13(1):25-34. PubMed ID: 17546902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of the amodiaquine+sulfadoxine-pyrimethamine combination and of chloroquine for the treatment of malaria in Córdoba, Colombia, 2006].
    Pérez MA; Cortés LJ; Guerra AP; Knudson A; Usta C; Nicholls RS
    Biomedica; 2008 Mar; 28(1):148-59. PubMed ID: 18645670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mother-to-child transmission of HIV-1: association with malaria prevention, anaemia and placental malaria.
    Naniche D; Lahuerta M; Bardaji A; Sigauque B; Romagosa C; Berenguera A; Mandomando I; David C; Sanz S; Aponte J; Ordi J; Alonso P; Menendez C
    HIV Med; 2008 Oct; 9(9):757-64. PubMed ID: 18651857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants.
    Kobbe R; Kreuzberg C; Adjei S; Thompson B; Langefeld I; Thompson PA; Abruquah HH; Kreuels B; Ayim M; Busch W; Marks F; Amoah K; Opoku E; Meyer CG; Adjei O; May J
    Clin Infect Dis; 2007 Jul; 45(1):16-25. PubMed ID: 17554695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of quinine plus sulfadoxine-pyremethamine for the treatment of uncomplicated falciparum malaria in Bangladesh.
    Thriemer K; Haque R; Wagatsuma Y; Salam MA; Akther S; Attlmayr B; Fukuda M; Schaecher K; Miller RS; Noedl H
    Am J Trop Med Hyg; 2006 Oct; 75(4):645-9. PubMed ID: 17038687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydrofolate reductase I164L mutations in Plasmodium falciparum isolates: clinical outcome of 14 Kenyan adults infected with parasites harbouring the I164L mutation.
    Hamel MJ; Poe A; Bloland P; McCollum A; Zhou Z; Shi YP; Ouma P; Otieno K; Vulule J; Escalante A; Udhayakumar V; Slutsker L
    Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):338-45. PubMed ID: 18321547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy of sulfadoxin/pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in Enseno, Meskan Woreda, Gurage zone, SNNPR, Ethiopia.
    Abebe W
    Ethiop Med J; 2006 Apr; 44(2):133-8. PubMed ID: 17447375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in Western Kenya.
    Green MD; van Eijk AM; van Ter Kuile FO; Ayisi JG; Parise ME; Kager PA; Nahlen BL; Steketee R; Nettey H
    J Infect Dis; 2007 Nov; 196(9):1403-8. PubMed ID: 17922406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.
    Filler SJ; Kazembe P; Thigpen M; Macheso A; Parise ME; Newman RD; Steketee RW; Hamel M
    J Infect Dis; 2006 Aug; 194(3):286-93. PubMed ID: 16826475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004.
    Patrick Kachur S; Schulden J; Goodman CA; Kassala H; Elling BF; Khatib RA; Causer LM; Mkikima S; Abdulla S; Bloland PB
    Trop Med Int Health; 2006 Apr; 11(4):441-51. PubMed ID: 16553927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of the failure of treatment with pyrimethamine-sulfadoxine in children with uncomplicated falciparum malaria.
    Sowunmi A; Fateye BA; Adedeji AA; Gbotosho GO; Happi TC; Bamgboye AE; Bolaji OM; Oduola AM
    Acta Trop; 2006 Apr; 98(1):6-14. PubMed ID: 16513078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.